Average Co-Inventor Count = 5.38
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (27 from 1,535 patents)
2. Evotec International Gmbh (2 from 13 patents)
3. Boehringer Ingelheim Pharma Gmbh & Co Kg (194 patents)
29 patents:
1. 12421218 - Substituted pyrazine-carboxamide derivatives
2. 12398143 - Imidazopyrazine derivatives and the use thereof as medicament
3. 12091399 - Phenyltetrazole derivatives as plasma kallikrein inhibitors
4. 11992494 - Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists
5. 11851418 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
6. 11766443 - Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists
7. 11760745 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
8. 11376258 - Purine derivatives and the use thereof as medicament
9. 11166958 - 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament
10. 11155539 - 4-pyridinylmethyl-morpholine derivatives and the use thereof as medicament
11. 11104670 - 4-pyrimidin-5-ylmethyl-morpholine derivatives and the use thereof as medicament
12. 10849907 - Imidazopyridine derivatives and the use thereof as medicament
13. 10793522 - Sulfonamides as inhibitors of the uptake of extracellular citrate
14. 10695334 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
15. 10501440 - Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors